Compliance Rate
Compliance Rate
42.86%
Compliant submissions
3
Incompliant submissions
4
Total trials
7
My Organizations' Clinical Trials
Showing 1025 of 2008 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/11/20
End: 06/06/23
Due: 06/06/24
Phase: N/A
Priority: Normal
Start: 11/15/21
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 06/19/17
Due: 06/19/18
Phase: N/A
Priority: Normal
Start: 11/26/14
End: 08/15/18
Due: 08/15/19
Phase: N/A
Priority: Normal
Start: 10/21/21
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 10/31/03
Due: 10/31/04
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 08/04/14
End: 01/23/20
Due: 01/23/21
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 10/01/24
Due: 10/01/25
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 10/31/00
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/17/18
End: 04/10/21
Due: 04/10/22
Phase: N/A
Priority: Normal
Start: 09/19/17
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/08/20
End: 10/31/24
Due: 10/31/25
A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 12/01/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 04/30/30
Due: 04/30/31
Phase: N/A
Priority: Normal
Start: 06/22/24
End: 08/03/24
Due: 08/03/25
Phase: N/A
Priority: Normal
Start: 06/19/18
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 12/31/22
Due: 12/31/23